122 related articles for article (PubMed ID: 22691516)
1. The response of HIV-associated lymphadenopathic Kaposi sarcoma to highly active antiretroviral therapy evaluated by 18F-FDG PET/CT.
Mankia SK; Miller RF; Edwards SG; Ramsay A; Lee SM
Clin Nucl Med; 2012 Jul; 37(7):692-3. PubMed ID: 22691516
[TBL] [Abstract][Full Text] [Related]
2. Whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography images before and after chemotherapy for Kaposi sarcoma and highly active antiretrovirus therapy.
Morooka M; Ito K; Kubota K; Minamimoto R; Shida Y; Hasuo K; Ito T; Tasato D; Honda H; Teruya K; Kikuchi Y; Ohtomo K
Jpn J Radiol; 2010 Dec; 28(10):759-62. PubMed ID: 21191742
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy alone is an effective treatment for lymphadenopathic kaposi sarcoma demonstrated by a clinical and F-18 FDG positron emission tomography/computed tomography response.
Mankia SK; Miller RF; Edwards SG; Ramsay A; Lee SM
Clin Oncol (R Coll Radiol); 2012 May; 24(4):309-11. PubMed ID: 22449790
[No Abstract] [Full Text] [Related]
4. (18)F-FDG PET/CT findings in a case with HIV (-) Kaposi sarcoma.
Ozdemir E; Poyraz NY; Keskin M; Kandemir Z; Turkolmez S
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):175-7. PubMed ID: 24119549
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with human immunodeficiency virus-associated Castleman's disease and Kaposi sarcoma, disorders associated with human herpes virus 8 infection.
Bertagna F; Biasiotto G; Rodella R; Giubbini R; Alavi A
Jpn J Radiol; 2010 Apr; 28(3):231-4. PubMed ID: 20437136
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET imaging in HIV infection and tuberculosis.
Sathekge M; Maes A; Van de Wiele C
Semin Nucl Med; 2013 Sep; 43(5):349-66. PubMed ID: 23905617
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT findings in an HIV-infected patient with systemic Kaposi sarcoma.
Yin L; Lin Z; Meng Z
Pol Arch Intern Med; 2021 Jan; 131(1):78-80. PubMed ID: 33306291
[No Abstract] [Full Text] [Related]
8. Usefulness of F-18 FDG PET/CT in a case of Kaposi sarcoma with an unexpected bone lesion.
Morooka M; Ito K; Kubota K; Yanagisawa K; Teruya K; Hasuo K; Shida Y; Minamimoto R; Kikuchi Y; Oka S
Clin Nucl Med; 2011 Mar; 36(3):231-4. PubMed ID: 21285687
[TBL] [Abstract][Full Text] [Related]
9. Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT.
Liu Y
Ann Nucl Med; 2011 Oct; 25(8):536-46. PubMed ID: 21674240
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.
Polizzotto MN; Millo C; Uldrick TS; Aleman K; Whatley M; Wyvill KM; O'Mahony D; Marshall V; Whitby D; Maass-Moreno R; Steinberg SM; Little RF; Yarchoan R
J Infect Dis; 2015 Oct; 212(8):1250-60. PubMed ID: 25828248
[TBL] [Abstract][Full Text] [Related]
11. Imaging of HIV-associated Kaposi sarcoma; F-18-FDG-PET/CT and In-111-bevacizumabscintigraphy.
van de Luijtgaarden A; van der Ven A; Leenders W; Kaal S; Flucke U; Oyen W; van der Graaf W
J Acquir Immune Defic Syndr; 2010 Aug; 54(4):444-6. PubMed ID: 20611036
[No Abstract] [Full Text] [Related]
12. Asymmetric relapse of an HIV-associated Kaposi sarcoma.
Bleibtreu A; Mahida B; Bouscarat F; Rioux C
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):555-556. PubMed ID: 27832310
[No Abstract] [Full Text] [Related]
13. Immune reconstitution inflammatory syndrome due to Mycobacterium avium complex successfully followed up using 18 F-fluorodeoxyglucose positron emission tomography-computed tomography in a patient with human immunodeficiency virus infection: A case report.
Namkoong H; Fujiwara H; Ishii M; Yagi K; Haraguchi M; Matsusaka M; Suzuki S; Asakura T; Asami T; Saito F; Fukunaga K; Tasaka S; Betsuyaku T; Hasegawa N
BMC Med Imaging; 2015 Jul; 15():24. PubMed ID: 26187282
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
[TBL] [Abstract][Full Text] [Related]
15. High FDG uptake on FDG-PET scan in HIV-1 infected patient with advanced disease.
Belkhir L; Jonckheere S; Lhommel R; Vandercam B; Yombi JC
Acta Clin Belg; 2011; 66(6):419-21. PubMed ID: 22338303
[TBL] [Abstract][Full Text] [Related]
16. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.
Martin C; Castaigne C; Tondeur M; Flamen P; De Wit S
HIV Med; 2013 Sep; 14(8):455-62. PubMed ID: 23517190
[TBL] [Abstract][Full Text] [Related]
17. FDG PET/CT in patients with HIV.
Davison JM; Subramaniam RM; Surasi DS; Cooley T; Mercier G; Peller PJ
AJR Am J Roentgenol; 2011 Aug; 197(2):284-94. PubMed ID: 21785073
[TBL] [Abstract][Full Text] [Related]
18. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy.
Leitch H; Trudeau M; Routy JP
HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778
[TBL] [Abstract][Full Text] [Related]
19. PET/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads.
Goshen E; Davidson T; Avigdor A; Zwas TS; Levy I
Clin Nucl Med; 2008 Sep; 33(9):610-4. PubMed ID: 18716509
[TBL] [Abstract][Full Text] [Related]
20. Two cases of 18F-FDG PET/CT findings in HIV-negative Kaposi's sarcoma. Original presentation of one case favorably treated with interferon.
Canbaz F; Ersoy D; Basoglu T
Hell J Nucl Med; 2011; 14(1):74-5. PubMed ID: 21512674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
